(Q29619849)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

30 April 2017

Bergers G

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

30 April 2017

Benjamin LE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

June 2003

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

30 April 2017

page(s)

401-10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

Rules for making human tumor cells

30 April 2017

cites work

1 reference

c-MYC: more than just a matter of life and death

31 March 2020

1 reference

Genetic alterations during colorectal-tumor development

31 March 2020

1 reference

31 March 2020

The Hallmarks of Cancer

1 reference

Mechanisms of normal and tumor-derived angiogenesis

31 March 2020

1 reference

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

31 March 2020

1 reference

Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis

31 March 2020

1 reference

Clinical translation of angiogenesis inhibitors

31 March 2020

1 reference

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

31 March 2020

1 reference

Mechanisms of angiogenesis and arteriogenesis

31 March 2020

1 reference

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

31 March 2020

1 reference

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

31 March 2020

1 reference

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

31 March 2020

1 reference

Vasculogenic mimicry and tumor angiogenesis

31 March 2020

1 reference

Vasculogenic mimicry: how convincing, how novel, and how significant?

31 March 2020

1 reference

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

31 March 2020

1 reference

Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors

31 March 2020

1 reference

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

31 March 2020

1 reference

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment

31 March 2020

1 reference

Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor

31 March 2020

1 reference

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

31 March 2020

1 reference

Vascular-specific growth factors and blood vessel formation

31 March 2020

1 reference

Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

31 March 2020

1 reference

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

31 March 2020

1 reference

VEGF and the quest for tumour angiogenesis factors

31 March 2020

1 reference

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

31 March 2020

1 reference

HIF-1 and tumor progression: pathophysiology and therapeutics

31 March 2020

1 reference

Activation of the HIF pathway in cancer

31 March 2020

1 reference

Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

31 March 2020

1 reference

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

31 March 2020

1 reference

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

31 March 2020

1 reference

Cyclooxygenase-2: a therapeutic target in angiogenesis.

31 March 2020

1 reference

Chemoprevention of prostate cancer: current status and future directions

31 March 2020

1 reference

Cyclooxygenase-2 and prostate carcinogenesis

31 March 2020

1 reference

High cyclooxygenase-2 expression in cervical adenocarcinomas

31 March 2020

1 reference

Induction of angiogenesis during the transition from hyperplasia to neoplasia

31 March 2020

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

31 March 2020

1 reference

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

31 March 2020

1 reference

VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis

31 March 2020

1 reference

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

31 March 2020

1 reference

Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow

31 March 2020

1 reference

Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

31 March 2020

1 reference

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

31 March 2020

1 reference

Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis

31 March 2020

1 reference

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

31 March 2020

1 reference

New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

31 March 2020

1 reference

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

31 March 2020

1 reference

The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: a clinicopathologic and flow cytometric study

31 March 2020

1 reference

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

31 March 2020

1 reference

In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects

31 March 2020

1 reference

Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomide

31 March 2020

1 reference

Effect of p53 status on tumor response to antiangiogenic therapy.

31 March 2020

1 reference

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

31 March 2020

1 reference

Hypoxia upregulates Bcl-2 expression and suppresses interferon-gamma induced antiangiogenic activity in human tumor derived endothelial cells.

31 March 2020

1 reference

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

31 March 2020

1 reference

Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes

31 March 2020

1 reference

Response of tumour cells to hypoxia: role of p53 and NFkB.

31 March 2020

1 reference

Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia

31 March 2020

1 reference

p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma

31 March 2020

1 reference

Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis

31 March 2020

1 reference

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

31 March 2020

1 reference

Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice

31 March 2020

1 reference

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

31 March 2020

1 reference

Anti-angiogenic drug AGM1470 suppresses smooth muscle cell migration induced by endothelial PDGF

31 March 2020

1 reference

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

31 March 2020

1 reference

Issues and progress with protein kinase inhibitors for cancer treatment

31 March 2020

1 reference

Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells

31 March 2020

1 reference

The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

31 March 2020

1 reference

Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin

31 March 2020

1 reference

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

31 March 2020

1 reference

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

31 March 2020

1 reference

Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice

31 March 2020

1 reference

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

31 March 2020

1 reference

Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter

31 March 2020

1 reference

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

31 March 2020

1 reference

Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis

31 March 2020

1 reference

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis

31 March 2020

1 reference

Human metalloproteinase-1 (collagenase-1) is a tumor suppressor protein p53 target gene

31 March 2020

1 reference

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

31 March 2020

1 reference

Inhibition of cyclooxygenase-2 gene expression by p53.

31 March 2020

1 reference

Angiostatin binds ATP synthase on the surface of human endothelial cells

31 March 2020

1 reference

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation

31 March 2020

1 reference

The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest

31 March 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

31 March 2020

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1034983802

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12778130

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017